Symposium Speakers



 3rd Joint Symposium of the Association of Physicians of Great Britain & Ireland and the Academy of Medical Sciences

"Multimorbidity – a global health research priority"

Friday, 29 March 2019, Glasgow


Professor Melanie Davies

"Multimorbidity Insights from the Diabetes Field"

Melanie Davies is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust, Leicester, UK. She is based in the Diabetes Research Centre, University of Leicester and is also the Co-Director of the Leicester Diabetes Centre, which has over 160 research staff, at the University Hospitals of Leicester NHS Trust.  She trained at Sheffield and then completed her training at Cambridge, Ipswich and Leicester.
Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus. She is a National Institute for Health Research Senior Investigator Emeritus and Director of the NIHR Leicester Biomedical Research Centre.  Professor Davies is the Principal Investigator on a number of large global studies in the field of diabetes, obesity, physical activity, sedentary behaviour and cardiovascular disease and has served as an expert for the National Institute for Health and Care Excellence (NICE) on a number of guideline groups.  Professor Davies was co-chair of EASD/ADA’s recent Consensus Report on T2DM Management.
Professor Davies has published over 560 original articles in national and international peer-reviewed journals, such as the Lancet, NEJM and the BMJ and has over £60M of peer review grant funding. She has over 510 published abstracts and 10 book chapters, and is Co-editor of the diabetes section in the 2011 Oxford Textbook of Endocrinology and Diabetes. She was awarded the CBE (Commander of the Most Excellent Order of the British Empire) in the 2016 New Year’s Honour’s List for services to diabetes research and awarded Fellowship of the Academy of Medical Sciences in 2018.


Professor Paul Elliott

"Multimorbidity: an MRC Perspective"

Paul Elliott is Clinical Professor of Epidemiology and Public Health Medicine in the School of Public Health at Imperial College London, and Honorary Consultant in Public Health at Imperial College NHS Healthcare Trust. His research program focuses on improving the understanding of the impact of, and interplay between, environmental and genetic factors on human health, in particular cardiovascular and metabolic diseases. In 2009, he established the MRC-PHE Centre for Environment and Health at Imperial in collaboration with academic colleagues at King’s College London. This is an internationally recognized centre of excellence in environmental sciences research and postgraduate training. Prof Elliott is deputy director of the NIHR Health Protection Research Unit in Health Impacts of Environmental Hazards, co-director of the MRC-NIHR National Phenome Centre, and associate director of Health Data Research UK London. He is a founding member of the UK Biobank, which has created a unique resource of data with unparalleled opportunities for research into long-term health. He leads large epidemiological cohort studies including the Airwave Health Monitoring Study of British police officers and staff, which is part of the Dementias Platform UK. He chairs the MRC Population and Systems Medicine Board and is contributing to the debate on tackling global public health issues by focusing on the burden of multimorbidity and identifying risk factors amenable to population level preventative strategies.


Professor Bruce Guthrie
"Multimorbidity: how should health services respond?"

Bruce Guthrie is Professor of General Practice at the University of Edinburgh, where he conducts applied research to translate basic and clinical research into effective and reliable clinical practice. He was previously Professor of Primary Care Medicine at the University of Dundee, and before that a Harkness Fellow in Healthcare Policy at the University of California, San Francisco. His research focuses on healthcare quality and safety, particularly for people with multimorbidity and polypharmacy, and particularly in relation to prescribing. His research spans the range from basic epidemiology, through the development and evaluation of complex interventions, to applied work with the National Health Service to improve care and to evaluate NHS improvement work. As well as conducting research, he continues to practice clinically, and is a member of a number of NHS advisory bodies, including chairing the guideline development group for the NICE guideline “Multimorbidity: Clinical Assessment and Management”.


Professor Frances Mair

"Providing Person Centred Care in Multimorbidity – The Importance of Treatment Burden and Risk Stratification"

Professor Frances Mair is the Norie Miller Professor of General Practice at the University of Glasgow.   Professor Mair has published >175 peer reviewed articles and undertakes mixed methods research focusing on optimising the care of patients with chronic illness and multimorbidity.  Her work takes into account the wider socioeconomic environment and social contexts in which patients live and the importance of understanding implementation issues to help bridge the translational gap between research and clinical practice.   She leads an extensive programme of chronic illness, multimorbidity and digital health research that promotes a move to person centred care, promoting the concept of “Minimally Disruptive Medicine (MDM)”  which has gained traction internationally, following a paper of that title , which she co-wrote and published in the British Medical Journal, that argued for the necessity of providing medicine that is minimally disruptive for patients.  She has led a range of research projects that examine multimorbidity issues including the largely unexplored phenomenon of  ‘treatment burden’.